Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04966000

Neurobiomarker for Prism Adaptation Treatment Response

Development of a Neuroimaging Biomarker to Identify Optimal Candidates for Prism Adaptation Treatment

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Utah · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Preliminary data will be collected about which individuals with spatial neglect from right hemisphere stroke (aiming vs perceptual neglect) improve with Prism Adaptation Training and if there is a particular pattern of damage in the brain that predicts both the type of neglect experienced and whether neglect is improved following Prism Adaptation Training

Detailed description

For preliminary data, twelve individuals with right hemisphere stroke and spatial neglect will participate. After pretesting for type of neglect and its severity, they will have an MRI with Diffusion Tensor Imaging (DTI). Then they will complete 10 sessions of Prism Adaptation Therapy and complete neglect post-testing. Response to Prism Adaptation Therapy will be assessed by comparing neglect scores pre- and post-training. Traditional lesion mapping, structural and functional lesion disconnectivity analyses, and tract-based spatial statistics of DTI measures will be used to examine whether any patterns of damage/dysfunction are related to a diagnosis of aiming neglect and response to Prism Adaptation Therapy.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPrism Adaptation TherapyParticipants wear goggles with built-in prisms (a 20-diopter lens) that shift the visual scene to the right. While wearing the googles they reach to and cross out 60 lines/circles, requiring them to learn to reach more leftward than the visual targets appear. Participants can only see the end of their movements.

Timeline

Start date
2023-01-01
Primary completion
2024-12-05
Completion
2024-12-05
First posted
2021-07-16
Last updated
2025-06-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04966000. Inclusion in this directory is not an endorsement.